CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 74 enrolled
Drug / intervention
Multicomponent interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06492590
NCT06492590N/ACompleted
CompareCT.gov

Assessing a Multicomponent Intervention to Improve Quality of Life in Individuals With Long COVID-19 (COVIDL/MIQoL): A Randomized Controlled Trial

Consorci Sanitari de Terrassa·interventional·Posted Jul 9, 2024·Updated Jan 16, 2026

In Brief

A clinical study evaluating Multicomponent intervention for Long COVID-19. Completed, enrolled 74 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to assess the effectiveness of a multicomponent intervention in individuals with Long COVID. The main questions it aims to answer are: * Does the intervention increase quality of life, mental well-being, resilience, and physical condition in individuals with Long COVID? * Does the intervention decrease anxiety, depressed mood, and fatigue in individuals with Long COVID? The researchers will compare the multicomponent intervention with a control (non-intervention) group. Participants will: • Participate in a multicomponent intervention for 9 weeks (2 sessions each week, one of psycho-education and one of physical rehabilitation).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLong COVID-19
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedJul 9, 2024
Enrollment StartJan 17, 2025
Primary CompletionSep 30, 2025
Study CompletionNov 30, 2025
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 2.0 years ago

Interventions

Multicomponent interventionbehavioral

Multicomponent intervention based on psycho-education and physical rehabilitation.